Comparison of carvedilol vs. bisoprolol for heart failure with reduced ejection fraction (HFrEF): A systematic review and meta-analysis from the Asian population
China, Indonesia, and Malaysia have the highest age-standardized rates of heart failure in Asia, according to the Global Burden of Disease study. While numerous systematic reviews and meta-analyses have compared bisoprolol and carvedilol in HFrEF, most have focused on Western populations. To address...
Saved in:
Main Authors: | Yedy Purwandi Sukmawan, Tita Nofianti, Anisa Pebiansyah |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2025-01-01
|
Series: | Pharmacia |
Online Access: | https://pharmacia.pensoft.net/article/142130/download/pdf/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Quality of Life in Heart Failure Reduced Ejection Fraction (HFrEF) Patients: A Phenomenon of Obesity Paradox
by: Yogi Puji Rachmawan, et al.
Published: (2025-01-01) -
Ivabradine and Milrinone—Bridge to Recovery in New HFrEF With Low-Output Heart Failure
by: Lekha Racharla, et al.
Published: (2024-01-01) -
Patterns of beta-blocker use and dose optimization among ambulatory heart failure patients with reduced ejection fraction (HFrEF) attending public hospitals in Northeast Ethiopia: a multi-center cross-sectional study
by: Minimize Hassen, et al.
Published: (2025-01-01) -
The comparative analysis of the influence of bisoprolol and carvedilol on the course of heart failure of ischemic origin in patients with concomitant atrial fibrillation and diabetes mellitus
by: N.M. Kulaiets, et al.
Published: (2024-11-01) -
Phenotypic Trajectories From Acute to Stable Phase in Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Study
by: Yuki Matsuoka, et al.
Published: (2025-02-01)